Cubist Systematic Strategies, LLC Mirum Pharmaceuticals, Inc. Put Options Transaction History
Cubist Systematic Strategies, LLC
- $15.6 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
230Shares Held
55.9MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$363 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$254 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$173 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$149 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$136 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.96B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...